IP Library Granted Patent US 9,321,999
Granted Patent B2
US 9,321,999 · App. 12/950,349 · Granted Apr 26, 2016

Compositions for increasing polypeptide stability and activity, and related methods

Inventors: Olev Kahre (Tartu, EP); Kadri Artma (Tartumaa, EP); Tiina Kahre (Tartu, EP)
Assignee: SOLIS BIODYNE OÜ
C12N9/00C07K14/00C12N9/1252C12N9/1276C12N9/14C12N9/22C12N9/50C12N9/78C12N9/96C07K2319/21C07K2319/35C07K2319/50
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,321,999
App. No.
12/950,349
Granted
Apr 26, 2016
Kind
B2
Abstract

This disclosure provides peptides, polypeptides, fusion polypeptides, compositions, and methods for enhancing or increasing the stability of a polypeptide (e.g., Taq polymerase). Such peptides, polypeptides, fusion polypeptides, or compositions include polypeptides linked to a peptide tag that enhances the stability of the polypeptide. The peptides, polypeptides, fusion polypeptides, compositions may also enhance the activity, specificity, and/or fidelity of other polypeptides in a reaction mixture. The disclosure also provides methods of using such peptides, polypeptides, fusion polypeptides, compositions.

Claims (20)

1. A method of increasing the thermal stability of a polypeptide comprising covalently linking the polypeptide at the amino-terminus to a peptide tag to form a fusion polypeptide, wherein:

(a) the peptide tag is at least 95% identical to SEQ ID NO: 1; and

(b) the fusion polypeptide does not have the amino acid sequence of SEQ ID NO: 2.

2. The method of claim 1 , wherein the peptide tag has an amino acid sequence of SEQ ID NO: 1 or SEQ ID NO: 16.

3. The method of claim 1 , wherein the peptide tag is encoded by a nucleic acid sequence of SEQ ID NO: 3 or SEQ ID NO: 17.

4. The method of claim 1 , wherein the peptide tag comprises at least three histidine residues.

5. The method of claim 1 , wherein the polypeptide is erythropoietin, human Leukemia Inhibitory Factor (hLIF), granulocyte macrophage colony-stimulating factor (GM-CSF), insulin, vascular endothelial growth factor (VEGF), leptin, or bevacizumab.

6. The method of claim 1 , wherein the fusion polypeptide comprises the amino acid sequence of SEQ ID NO: 20 or SEQ ID NO: 22.

7. The method of claim 1 , wherein the polypeptide is a thermostable protein or enzyme.

8. The method of claim 7 , wherein the enzyme is a polymerase, reverse transcriptase, nuclease, pyrophosphatase, deaminase, or protease.

9. The method of claim 8 , wherein the polymerase is a DNA polymerase I, Thermus aquaticus DNA polymerase I (Taq), Thermococcus gorgonarius DNA polymerase (Tgo), Thermus thermophilics (Tth) DNA polymerase, or ZO5 DNA polymerase.

10. The method of claim 8 , wherein the pyrophosphatase is a Thermoplasma acidophilum pyrophosphatase (TAPP).

11. The method of claim 8 , wherein the deaminase is a Pyrococcus horikoshii dCTP deaminase.

12. The method of claim 7 , wherein the thermostable protein is a cosmetic peptide or polypeptide.

13. The method of claim 1 , wherein the polypeptide comprises at least two polypeptides.

14. The method of claim 13 , wherein the polypeptide comprises an enzyme and a double strand binding protein.

15. The method of claim 14 , wherein the double strand binding protein comprises an amino acid sequence of SEQ ID NO: 10.

16. The method of claim 1 , wherein the peptide tag is at least 98% identical to SEQ ID NO:1.

17. The method of claim 1 , wherein covalently linking the polypeptide causes the polypeptide to have thermal stability at 35° C.

18. The method of claim 1 , wherein covalently linking the polypeptide causes the polypeptide to have thermal stability at −20° C.

Assignments (2)
CHANGE OF NAME Recorded Feb 12, 2016
From: OÜ SOLIS BIODYNE
To: SOLIS BIODYNE OÜ
Reel/Frame 037813/0029 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 24, 2011
From: KAHRE, OLEV; ARTMA, KADRI; KAHRE, TIINA
To: OU SOLIS BIODYNE
Reel/Frame 025861/0315 →
Continuity (5)
Provisional Application 61390857 · Oct 7, 2010
Provisional Application 61356541 · Jun 18, 2010
Provisional Application 61350457 · Jun 1, 2010
Provisional Application 61262919 · Nov 19, 2009
Related Publication 20110142792A1 · Jun 16, 2011